Introduction
Dysphagia is a recognized complication of idiopathic Parkinson's disease but it is not widely appreciated that significant dysphagia may also occur in drug-induced parkinsonism and in other syndromes associated with major tranquillizers.
Case report
In 1976 a 41 year old woman presented with discoid lupus confirmed on skin biopsy and was treated successfully with topical steroids. In 1984 she presented with agitated depression with some psychotic features and required admission to hospital. She improved with flupenthixol 20 mg every 2 weeks. In December 1990 she presented with weight loss, malaise and myalgia. Investigations included haemoglobin (Hb) 7.1 g/l, platelets 132 x 109/l, white blood cell count 2.4 x 109/l, ESR 78 mm in one hour, anti-nuclear factor (ANF) of 1/320, antibody to double-stranded DNA (anti-DNA) of 1/320 and subnormal levels of complement C3 and C4. A diagnosis of systemic lupus erythematosus (SLE) was made and she responded well to prednisolone and azathioprine. In December 1991 she became hyperactive with impaired memory and judgement, and required hospital admission for worsening agitation and paranoia. There was no evidence ofactive SLE and her symptoms were eventually controlled with medication; drugs prescribed on discharge in March 1992 were flupenthixol 20 mg every 2 weeks, procyclidine 5 mg three times a day, haloperidol 1.5 mg and diazepam 10 mg four times a day, prednisolone 15 mg daily and azathioprine 25 mg three times a day.
In June 1992, whilst still on the medication listed above, she presented with an 8 week history of worsening, intermittent, painless dysphagia for solids and liquids with accompanying weight loss of 10 kg. She had no other specific complaints. There was no other past medical history of note. She was a retired schoolteacher, married with two children and had no family history of neurological or psychiatric disease.
On admission she weighed 33 kg, was clearly malnourished but walked unaided. She had marked postural hypotension and inspiratory crackles were audible at the left lung base; abdominal examination was normal. She was agitated and restless. Cranial nerve examination revealed a lack of facial expression, but palatal and pharyngeal sensation and reflexes were normal and tongue movements were normal. She had a quiet hoarse voice with a persistent productive cough and on attempting to drink water she coughed violently during and after the first mouthful and was unable to proceed. She had cogwheel rigidity and some bradykinesia in the limbs but no other neurological signs.
Investigations revealed a normochromic normocytic anaemia with Hb 10.7 g/l, ESR 70 mm/hour, C-reactive protein (CRP) 116 mg/I (normal range 1-4), normal complement levels, normal chest X-ray, negative ANF and a negative anti-DNA. A computerized tomographic scan of the brain and cerebrospinal fluid examination were normal. Indirect laryngoscopy showed chronic inflammation of the larynx, pooling of secretions and saliva in the pyriform fossae but normal move-ments ofthe vocal cords. Videofluoroscopy showed complete failure of laryngeal elevation and closure, and failure of cricopharyngeal opening. Pooling occurred in the pyriform fossae and above the cricopharyngeus, and there was aspiration of contrast into the larynx and trachea (Figure 1 ). 
In the absence of a structural lesion or of evidence of active SLE causing her dysphagia, her neuroleptic medication was suspected, particularly in view of her definite but mild extrapyramidal signs. Her case was discussed with her psychiatrist and over the next 8 days the haloperidol was stopped and the procyclidine and diazepam each reduced to 5 mg twice a day; the dosages of other drugs were not changed. Since she had clinical and radiographic evidence of aspiration, oral feeding was stopped and a nasogastric tube used. Two weeks later she was able to swallow clear fluids. The speech therapist and dietician then gradually introduced suitable textures of food and after 6 weeks the patient was taking a normal diet without difficulty. On discharge repeat videofluoroscopy showed normal elevation of the larynx and normal opening of the cricopharyngeus without pooling or aspiration ( Figure 2 ); ESR and CRP were normal and her weight had increased to 41.4 kgs. Despite the withdrawal of haloperidol there was an improvement in her psychiatric symptoms during this period.
Discussion
In this case a patient with SLE already on longterm flupenthixol treatment developed severe dysphagia following the addition of haloperidol, procyclidine and diazepam to her treatment. Following withdrawal of the haloperidol and a reduction in the dosage of diazepam and procyclidine the swallowing problem gradually resolved suggesting that it was the addition of haloperidol to the existing treatment that was mainly responsible for the dysphagia.
The mild signs of parkinsonism, the absence of any lower cranial nerve signs and the videofluoroscopy findings ofcomplete failure ofvoluntary and reflex swallowing suggests that the drugs produced an akinesia or bradykinesia of the swallowing process; the term 'bradykinetic dysphagia' has been used by other authors to describe this type of problem.' There was no good evidence of a dystonia of the larynx or pharynx or of tardive dyskinesia, both of which cause swallowing problems and have been associated with drugs of the major tranquillizer group.2'3 The evidence for SLE being active during the illness was poor; the initially abnormal ESR was probably the result of lung infection secondary to aspiration as it returned to normal with management of the dysphagia alone. The small reduction in the dose ofprocyclidine may have contributed to the improvement seen but recovery occurred despite continuation of the drug at a dose of 10 mg/day.
An assessment of swallowing is not routinely included in the clinical examination ofpatients who are on large doses of major tranquillizers despite reports suggesting an association between these drugs and unexplained fatal choking episodes in psychiatric in-patients.4 Some authors have suggested that the gag reflex should be regularly observed in patients on neuroleptic drugs thought to be at risk of developing a swallowing problem.'
If closely observed the gag reflex may give useful information about the sensory and motor innervation of the palate and the posterior pharyngeal wall, but it does not provide information about swallowing; as in this case a patient may have severe dysphagia and exhibit all the components of a normal gag reflex. For this reason observation of the patient actually swallowing is an essential part of the bedside examination; obvious caution and slowing of drinking, coughing during swallowing, an alteration in voice quality post swallow or difficulty in initiating a swallow when the bolus is held in the mouth are easily detected warning signs of impaired swallowing. Conversely, if recurrent chest infections, cough or unexplained weight loss raise the possibility of aspiration in this group of patients, a detailed clinical evaluation supported by videofluoroscopy should be carried out.
The case demonstrates the dramatic effect neuroleptic medication may have on swallowing. Dysphagia may be associated with a significant morbidity and mortality in patients on neuroleptic drugs, and a high level of clinical awareness and regular observation of the patient swallowing may help to improve detection of this problem. 
